protein degradation

Graphic of two hands shaking under a red and purple light
Biotech

Sanofi pays Nurix $15M upfront for autoimmune degrader

Sanofi is paying $15 million and committing up to $465 million for exclusive rights to a degrader of a once-undruggable transcription factor.
Nick Paul Taylor Apr 2, 2025 8:10am
Cartoon of magnet pulling coins toward it

Eli Lilly feels Magnet's pull with hefty molecular glue deal

Feb 28, 2025 6:30am
glue scissors art supplies

AbbVie crafts $1.6B deal with molecular glue biotech Neomorph

Jan 23, 2025 9:58am
pivot change turnaround direction walk away

Kymera pivots to immunology, seeks partners for cancer assets

Nov 1, 2024 11:46am
Bottle of glue

Biogen buys in to molecular glues with deal worth up to $1.45B

Oct 30, 2024 10:50am
Audience at rock concert

Novartis inks $150M deal for autoimmune molecular glue

Oct 28, 2024 7:00am